Oceania Healthcare Limited (NZE:OCA)
New Zealand · Delayed Price · Currency is NZD 0.7350
-0.0150 (-2.00%)
Oct 1, 2026, 5:00 PM NZST
Oceania Healthcare Ratios and Metrics
Market cap in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 532 | 507 | 442 | 456 | 526 | 746 | |
Market Cap Growth | 8.09% | 14.75% | -3.16% | -13.27% | -29.46% | -15.09% |
Enterprise Value | 1,042 | 1,119 | 1,079 | 1,069 | 1,028 | 1,090 |
Last Close Price | 0.73 | 0.70 | 0.61 | 0.63 | 0.72 | 0.99 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 4473.19 | 4260.18 | 14.53 | 14.50 | 34.05 | 12.20 |
Forward PE | 7.32 | 7.54 | 7.26 | 6.20 | 7.29 | 11.11 |
PS Ratio | 1.98 | 1.89 | 1.68 | 1.72 | 2.13 | 3.23 |
PB Ratio | 0.45 | 0.43 | 0.40 | 0.44 | 0.55 | 0.79 |
P/TBV Ratio | 0.45 | 0.43 | 0.40 | 0.45 | 0.55 | 0.79 |
P/FCF Ratio | 3.51 | 3.35 | 6.31 | 9.09 | 37.30 | 15.15 |
P/OCF Ratio | 3.14 | 2.99 | 4.01 | 4.41 | 7.49 | 7.07 |
PEG Ratio | 0.77 | 0.58 | 0.75 | 0.65 | 0.60 | 0.55 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 3.88 | 4.16 | 4.11 | 4.03 | 4.16 | 4.72 |
EV/EBITDA Ratio | 215.21 | 443.36 | - | 157.65 | 78.98 | 120.78 |
EV/FCF Ratio | 6.88 | 7.38 | 15.41 | 21.31 | 72.89 | 22.14 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.45 | 0.45 | 0.58 | 0.64 | 0.58 | 0.41 |
Debt / EBITDA Ratio | 108.76 | 108.76 | 347.09 | 73.31 | 36.97 | 33.15 |
Debt / FCF Ratio | 3.48 | 3.48 | 9.11 | 12.99 | 39.59 | 7.92 |
Net Debt / Equity Ratio | 0.43 | 0.43 | 0.57 | 0.63 | 0.57 | 0.40 |
Net Debt / EBITDA Ratio | 202.22 | 202.22 | -1230.50 | 94.96 | 42.33 | 42.14 |
Net Debt / FCF Ratio | 3.37 | 3.37 | 8.99 | 12.84 | 39.06 | 7.72 |
Asset Turnover | 0.09 | 0.09 | 0.09 | 0.10 | 0.10 | 0.11 |
Quick Ratio | 0.12 | 0.12 | 0.11 | 0.12 | 0.12 | 0.10 |
Current Ratio | 0.12 | 0.12 | 0.11 | 0.17 | 0.23 | 0.10 |
Return on Equity (ROE) | 0.01% | 0.01% | 2.86% | 3.16% | 1.62% | 6.86% |
Return on Assets (ROA) | -0.38% | -0.38% | -0.43% | -0.22% | -0.06% | -0.20% |
Return on Invested Capital (ROIC) | -1.08% | -1.06% | -1.15% | -0.60% | -0.15% | -0.53% |
Return on Capital Employed (ROCE) | -1.00% | -1.00% | -1.10% | -0.50% | -0.10% | -0.50% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 0.02% | 0.02% | 6.88% | 6.90% | 2.94% | 8.20% |
FCF Yield | 28.47% | 29.90% | 15.85% | 11.00% | 2.68% | 6.60% |
Dividend Yield | - | - | - | - | 4.46% | 4.46% |
Payout Ratio | - | - | - | 21.49% | 141.16% | 31.77% |
Buyback Yield / Dilution | - | - | -0.08% | -1.12% | -1.46% | -13.49% |
Total Shareholder Return | - | - | -0.08% | -1.12% | 3.00% | -9.03% |